Tag: bartonellosis market forecast

Uncover key drivers, emerging technologies, and competitive movements shaping the bartonellosis market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Bartonellosis Market reach by 2030 starting from 2026 levels?

The bartonellosis market has seen considerable expansion in recent years. It is anticipated to expand from $1.3 billion in 2025 to $1.46 billion by 2026, achieving a compound annual growth rate (CAGR) of 11.7%. Historically, this growth can be ascribed to several factors, including an escalating incidence of cat scratch disease, enhanced diagnostic proficiencies for infectious diseases, the availability of antibiotic treatments, the proliferation of hospital diagnostic laboratories, and heightened clinician awareness concerning bartonella infections.

The bartonellosis market size is anticipated to experience substantial expansion over the upcoming years. By 2030, this market is projected to reach $2.24 billion, demonstrating a compound annual growth rate (CAGR) of 11.3%. This projected growth during the forecast period is primarily driven by factors such as the accelerated development of rapid diagnostic assays, an amplified emphasis on timely intervention for systemic infections, the broadening of specialized infectious disease care services, the increasing uptake of precise antibiotic treatment plans, and heightened investment in research concerning zoonotic diseases. Key trends anticipated within the forecast period encompass a greater embrace of molecular diagnostic methodologies, a surge in the application of PCR-based testing, heightened public consciousness regarding zoonotic infections, the broadening of specific antibiotic treatment protocols, and an intensified concentration on identifying diseases at early stages.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21111&type=smp

Which Drivers Are Influencing Long-Term Growth In The Bartonellosis Market?

The increasing occurrences of zoonotic diseases are projected to stimulate the growth of the bartonellosis market moving forward. Zoonotic diseases are defined as illnesses transmitted from animals to humans, either directly or via vectors. The escalation in zoonotic disease incidences is attributed to factors such as enhanced human-animal interactions, environmental alterations, deforestation, global travel, and the spread of pathogens between species. Bartonellosis serves as a prime example of zoonotic diseases, demonstrating how bacterial pathogens, conveyed through animal vectors like fleas, ticks, and lice, can infect humans, leading to diverse clinical symptoms and underscoring the vital importance of understanding vector-borne disease transmission in public health. For instance, in December 2024, the European Food Safety Authority (EFSA) and European Centre for Disease Prevention and Control (ECDC), a Europe-based public health authority, reported human campylobacteriosis cases rose to 148,181, reflecting a 4.3% year-over-year increase from 139,225 cases in 2022. Similarly, salmonellosis cases climbed to 77,486, marking a 16.9% growth compared to 65,478 cases in 2022. Thus, the rise in incidences of zoonotic diseases is propelling the expansion of the bartonellosis market.

Which Segments Are Driving Activity In The Bartonellosis Market?

The bartonellosis market covered in this report is segmented –

1) By Disease Type: Cat Scratch Disease (CSD), Trench Fever, Bartonella Endocarditis, Other Disease Types

2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing, Serological Testing, Culture Methods, Histological Testing

3) By Treatment: Antibiotics, Antibacterial Agents, Supportive Care

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Cat Scratch Disease (CSD): Immunocompetent Hosts, Immunocompromised Hosts, Neurological Complications

2) By Trench Fever: Acute Trench Fever, Chronic Trench Fever, Asymptomatic Infections

3) By Bartonella Endocarditis: Native Valve Endocarditis, Prosthetic Valve Endocarditis, Bloodstream Infections

4) By Other Disease Types: Bacillary Angiomatosis, Parinaud’s Oculoglandular Syndrome, Bartonella-associated Vasculitis

Which Trends Are Expected To Influence The Bartonellosis Market In The Upcoming Years?

Leading companies active in the Bartonellosis market are increasingly concentrating on technological advancements, such as multi-microbial phage modulation, to achieve a competitive edge. This multi-microbial phage modulation involves utilizing customized phage cocktails designed to target multiple intracellular pathogens concurrently, addressing the co-infections that frequently complicate Bartonella treatment. For instance, in November 2024, Biologix Center, a US-based biotechnology company, introduced Induced Native Phage Cocktails intended for patients with Bartonella and Babesia co-infections. This therapy incorporates pathogen-specific phage activation, daily adaptive dosing customized to patient microbial profiles, and improved penetration into persistent infection reservoirs. This innovation facilitates a comprehensive approach to complex co-infections, diminishes dependency on conventional antibiotics, and supports precision medicine strategies. By leveraging multi-microbial phage therapy, companies are progressing personalized treatment solutions within the Bartonellosis market, while also navigating the clinical validation and regulatory pathways characteristic of emerging biologic therapies.

Which Key Players Are Driving Competition In The Bartonellosis Market?

Major companies operating in the bartonellosis market are Mayo Clinic Laboratories, Northwell Health Labs, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., Alberta Precision Laboratories, Jiangsu BioPerfectus Technologies Co. Ltd., ARUP Laboratories, Surmodics Inc., Medical Diagnostic Laboratories LLC, Creative Biolabs, IGeneX Inc., Karius Inc., Synnovis Group LLP, Galaxy Diagnostics Inc., Gold Standard Diagnostics, Eurofins Biomnis, AMMAGENOMICS Private Limited, Ringbio

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/bartonellosis-global-market-report

Which Region Is Projected To Lead The Bartonellosis Market During The Forecast Period?

North America was the largest region in the bartonellosis market in 2025. The regions covered in the bartonellosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Bartonellosis Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21111&type=smp

Browse Through More Reports Similar to the Global Bartonellosis Market 2026, By The Business Research Company

Hospital Acquired Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/hospital-acquired-infection-control-global-market-report

Infection Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report

Anti Infective Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Bartonellosis Market In The Coming Years?

The bartonellosis market is seeing rapid growth recently. The market, valued at $1.17 billion in 2024, is projected to increase to $1.3 billion in 2025, representing a Compound Annual Growth Rate (CAGR) of 11.7%. Factors contributing to this growth trend during the historic period include rising cases of Bartonella disease, augmented healthcare spending, increased investment in research and development, growing incidence of communicable diseases, and a surge in infectious disease prevalence.

The market size for bartonellosis is predicted to witness a significant surge in the coming years, reaching $2.02 billion in 2029, with a compound annual growth rate (CAGR) of 11.5%. The growth during this forecasted timeline can be linked to the increasing cases of zoonotic diseases, heightened understanding of the disease, a rise in pet ownership, an increased focus on individualized medication, and escalating awareness about cat scratch disease. Noteworthy trends during this period comprise improvements in medical technology, progress in biotechnology, the emergence of combined test procedures, advancements in diagnostic methods, and continuous research and innovation.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21111&type=smp

Which Market Dynamics Are Playing A Critical Role In The Growth Of The Bartonellosis Market?

An upward trend in zoonotic diseases is projected to stimulate the growth of the bartonellosis market in the future. Zoonotic diseases are health conditions transferred from animals to humans directly or indirectly through carriers. Such diseases have experienced a surge due to various factors like increased interaction with animals, changes in the environment, deforestation, worldwide travel, and the interspecies spread of pathogens. Bartonellosis has a pivotal role in zoonotic diseases, illustrating how bacterial pathogens carried by animal vectors like fleas, ticks, and lice can cause various clinical symptoms in humans. This emphasizes the need to comprehend the transmission of vector-borne diseases for public health. As an example, the Canadian government reported in January 2023 that 159 rabies samples were submitted in November 2022, a rise from 135 in October 2022. Hence, the increase in zoonotic diseases significantly contributes to the expansion of the bartonellosis market.

Which Sub-Segments Are Driving Growth Within The Bartonellosis Market?

The bartonellosismarket covered in this report is segmented –

1) By Disease Type: Cat Scratch Disease (CSD); Trench Fever; Bartonella Endocarditis; Other Disease Types

2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing; Serological Testing; Culture Methods; Histological Testing

3) By Treatment: Antibiotics; Antibacterial Agents; Supportive Care

4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Other End-Users

Subsegments:

1) By Cat Scratch Disease (CSD): Immunocompetent Hosts; Immunocompromised Hosts; Neurological Complications

2) By Trench Fever: Acute Trench Fever; Chronic Trench Fever; Asymptomatic Infections

3) By Bartonella Endocarditis: Native Valve Endocarditis; Prosthetic Valve Endocarditis; Bloodstream Infections

4) By Other Disease Types: Bacillary Angiomatosis; Parinaud’s Oculoglandular Syndrome; Bartonella-associated Vasculitis

What Current And Upcoming Trends Are Shaping The Bartonellosis Market?

Key players in the bartonellosis market are putting an emphasis on gathering funds with the goal of enhancing early detection and improving available treatments for the disease. These fundraising efforts consist of activities by various organizations aiming to collect resources that further the research, diagnosis, prevention, and management of bartonellosis. This contributes significantly toward fostering innovation and increasing the availability of healthcare solutions for the disease. An example of this occurred in April 2022, when the Global Lyme Alliance (GLA), an American non-profit, initiated a crowdfunding campaign with the objective of accumulating $300,000 to fund revolutionary research on Bartonella, an elusive pathogen responsible for severe health problems such as neuroinflammation and psychiatric disorders. This campaign, which was timed to coincide with Lyme disease awareness month, is intended to deepen understanding of how Bartonella acts within the body, information that is critical in creating more effective treatments for Bartonella infections and associated conditions like Lyme disease. The campaign underscores the call for greater awareness and financial input to assist those impacted by these incapacitating diseases.

Which Players Are Shaping The Competitive Landscape Of The Bartonellosis Market?

Major companies operating in the bartonellosis market are Mayo Clinic Laboratories, Northwell Health Labs, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., Alberta Precision Laboratories, Jiangsu BioPerfectus Technologies Co. Ltd., ARUP Laboratories, Surmodics Inc., Medical Diagnostic Laboratories LLC, Creative Biolabs, IGeneX Inc., Karius Inc., Synnovis Group LLP, Galaxy Diagnostics Inc., Gold Standard Diagnostics, Eurofins Biomnis, AMMAGENOMICS Private Limited, Ringbio

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/bartonellosis-global-market-report

How Do Regional Dynamics Influence The Bartonellosis Market Performance?

North America was the largest region in the bartonellosis market in 2024. The regions covered in the bartonellosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21111&type=smp

Browse Through More Reports Similar to the Global Bartonellosis Market 2025, By The Business Research Company

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Bacterial And Plasmid Vector Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bacterial-and-plasmid-vector-global-market-report

Antibacterial Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antibacterial-products-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Bartonellosis Market Size Likely To Evolve From 2025 Through 2034?

The bartonellosis market has seen swift expansion in recent years. It is anticipated to expand from $1.17 billion in 2024 to $1.3 billion in 2025, at a compound annual growth rate (CAGR) of 11.7%. The observed growth in the past can be linked to the escalating incidence of Bartonella disease, increased expenditure on healthcare, enhanced funding for research and development, a rise in transmissible illnesses, and the growing occurrence of infectious diseases.

The bartonellosis market size is predicted to experience significant expansion over the next few years. It is estimated to reach $2.02 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.5%. This projected growth is fueled by factors such as the increasing incidence of zoonotic diseases, greater awareness of the disease, an expanding number of pet owners, a heightened focus on personalized medicine, and rising understanding of cat scratch disease. Prominent trends expected during this forecast period include advancements in medical technology, progress in biotechnology, the creation of combined testing solutions, improvements in diagnostic methods, and ongoing research and development initiatives.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21111&type=smp

What Are The Main Drivers Boosting The Bartonellosis Industry’s Expansion?

The projected increase in the occurrence of zoonotic illnesses is expected to stimulate the expansion of the bartonellosis market moving forward. Zoonotic diseases are health conditions transferred from animals to humans, either directly or through intermediate carriers. This rise in zoonotic disease incidences is attributed to factors such as heightened human-animal interactions, shifts in environmental conditions, deforestation, global travel, and the spread of pathogens across various species. Bartonellosis exemplifies zoonotic diseases by showcasing how bacterial pathogens, transmitted via animal vectors like fleas, ticks, and lice, can infect humans, leading to a spectrum of clinical manifestations and highlighting the critical importance of understanding vector-borne disease transmission in public health. For instance, in January 2023, as per a report from the Government of Canada, a Canada-based federal authority, there were 159 rabies samples submitted in November 2022, which was an increase from 135 rabies samples submitted in October 2022. Hence, the increasing frequency of zoonotic diseases is a significant driver for the growth of the bartonellosis market.

What Are The Leading Segments Analyzed In The Bartonellosis Market?

The bartonellosismarket covered in this report is segmented –

1) By Disease Type: Cat Scratch Disease (CSD); Trench Fever; Bartonella Endocarditis; Other Disease Types

2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing; Serological Testing; Culture Methods; Histological Testing

3) By Treatment: Antibiotics; Antibacterial Agents; Supportive Care

4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Other End-Users

Subsegments:

1) By Cat Scratch Disease (CSD): Immunocompetent Hosts; Immunocompromised Hosts; Neurological Complications

2) By Trench Fever: Acute Trench Fever; Chronic Trench Fever; Asymptomatic Infections

3) By Bartonella Endocarditis: Native Valve Endocarditis; Prosthetic Valve Endocarditis; Bloodstream Infections

4) By Other Disease Types: Bacillary Angiomatosis; Parinaud’s Oculoglandular Syndrome; Bartonella-associated Vasculitis

What Trends Are Redefining The Bartonellosis Market Dynamics?

Major companies operating in the bartonellosis market are focusing on fundraising efforts to improve early detection and enhance therapeutic options for the disease. These fundraising efforts involve initiatives by organizations to raise funds that support the research, diagnosis, treatment, and prevention of bartonellosis, playing a vital role in driving innovation and improving access to healthcare solutions for the disease. For instance, in April 2022, the Global Lyme Alliance (GLA), a US-based nonprofit organization, launched a crowdfunding campaign aimed at raising $300,000 for groundbreaking research on Bartonella, a hidden pathogen that can cause serious health issues, including neuroinflammation and psychiatric disorders. This initiative coincided with Lyme disease awareness month and seeks to enhance understanding of Bartonella’s behavior in the body, which is crucial for developing more effective treatments for both Bartonella infections and related conditions like Lyme disease. The campaign emphasizes the need for increased awareness and funding to support those affected by these debilitating diseases.

Who Are The Key Multinational Companies Dominating The Bartonellosis Market?

Major companies operating in the bartonellosis market are Mayo Clinic Laboratories, Northwell Health Labs, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., Alberta Precision Laboratories, Jiangsu BioPerfectus Technologies Co. Ltd., ARUP Laboratories, Surmodics Inc., Medical Diagnostic Laboratories LLC, Creative Biolabs, IGeneX Inc., Karius Inc., Synnovis Group LLP, Galaxy Diagnostics Inc., Gold Standard Diagnostics, Eurofins Biomnis, AMMAGENOMICS Private Limited, Ringbio

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/bartonellosis-global-market-report

What Regional Growth Trends Are Shaping The Bartonellosis Market Outlook?

North America was the largest region in the bartonellosis market in 2024. The regions covered in the bartonellosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Bartonellosis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21111&type=smp

Browse Through More Reports Similar to the Global Bartonellosis Market 2025, By The Business Research Company

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Bacterial And Plasmid Vector Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bacterial-and-plasmid-vector-global-market-report

Antibacterial Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antibacterial-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Bartonellosis Market, and What Factors Will Drive It?

The market capacity of bartonellosis has experienced a swift expansion in the last few years. The market is projected to escalate from $1.17 billion in 2024 to $1.3 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.7%. Factors like the growing incidence of Bartonella disease, heightened healthcare spending, increased allocations for research and development, the upsurge in transmissible diseases, and an increase in the prevalence of infectious ailments, have contributed to this growth during the historical period.

Anticipated to experience rapid expansion in the coming years, the bartonellosis market is set to reach$2.02 billion in 2029″ with a compound annual growth rate (CAGR) of 11.5%. This growth trajectory projected during the forecast period can be linked to a rise in cases of zoonotic diseases, heightened awareness of the disease, an increase in pet ownership, more focus on personalized medicine, and better understanding of cat-scratch disease. Key trends that will be seen during this time are the progression of medical technology and biotechnology, the emergence of combined testing, advancements in diagnosing methods, and continuous research and development efforts.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21111&type=smp

What Are the Core Market Drivers Propelling Growth in the Bartonellosis Industry?

The bartonellosis market is poised for growth, primarily driven by the upsurge in instances of zoonotic illnesses. These are diseases that animals transmit to humans, usually directly or via vectors. The increase in zoonotic disease occurrences is attributed to factors such as growing human-animal interactions, variations in the environment, deforestation, international travel, and cross-species spread of pathogens. Bartonellosis demonstrates how bacterial pathogens transferred from animal vectors like fleas, ticks, and lice, can contaminate humans. This results in diverse clinical symptoms and underscores the significance of understanding the transmission of vector-borne diseases in relation to public health. For instance, a report published by the Government of Canada, a federal authority, in January 2023 stated that the number of rabies samples submitted in November 2022 had risen to 159 from 135 in October 2022. As a result, the increase in zoonotic disease occurrences underpins the expansion of the bartonellosis market.

How Is the Bartonellosis Market Segmented?

The bartonellosismarket covered in this report is segmented –

1) By Disease Type: Cat Scratch Disease (CSD); Trench Fever; Bartonella Endocarditis; Other Disease Types

2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing; Serological Testing; Culture Methods; Histological Testing

3) By Treatment: Antibiotics; Antibacterial Agents; Supportive Care

4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Other End-Users

Subsegments:

1) By Cat Scratch Disease (CSD): Immunocompetent Hosts; Immunocompromised Hosts; Neurological Complications

2) By Trench Fever: Acute Trench Fever; Chronic Trench Fever; Asymptomatic Infections

3) By Bartonella Endocarditis: Native Valve Endocarditis; Prosthetic Valve Endocarditis; Bloodstream Infections

4) By Other Disease Types: Bacillary Angiomatosis; Parinaud’s Oculoglandular Syndrome; Bartonella-associated Vasculitis

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=21111&type=smp

Which Regions Are Driving the Next Phase of the Bartonellosis Market Growth?

North America was the largest region in the bartonellosis market in 2024. The regions covered in the bartonellosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Market Trends and Innovations Are Shaping the Future of the Bartonellosis Industry?

Key corporations in the bartonellosis sector are prioritizing fundraising in an effort to advance early detection and improve therapeutic interventions for the disease. These fundraising activities carried out by these organizations are critical in funding research, diagnosis, treatment, and prevention of bartonellosis, thus spurring innovation and escalating access to healthcare solutions for the disease. For instance, the Global Lyme Alliance (GLA), a non-profit organization based in the US, launched a significant crowdfunding campaign in April 2022, with the goal of raising $300,000 for innovative Bartonella research. Bartonella is a concealed pathogen that can give rise to severe health problems, such as neuroinflammation and psychiatric disorders. This initiative coincides with Lyme disease awareness month, aiming to amplify our comprehension of Bartonella’s behavior within the body– knowledge paramount to the development of more successful treatments for Bartonella infections and conditions connected to it, like Lyme disease. This campaign underlines the need for intensifying awareness and financial support for those tormented by these incapacitating diseases.

View the full report here:

https://www.thebusinessresearchcompany.com/report/bartonellosis-global-market-report

How Is the Bartonellosis Market Defined and What Are Its Core Parameters?

Bartonellosis is a bacterial infection caused by the Bartonella genus, impacting the skin, lymph nodes, and internal organs. Early diagnosis and antibiotic treatment are essential to prevent severe systemic complications and ensure effective disease management.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21111

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Bartonellosis Market?

The market for bartonellosis has experienced impressive growth in the last few years. Forecasts predict the market will escalate from $1.17 billion in 2024 to $1.31 billion in 2025, following a compound annual growth rate of 12.0%. This significant growth in the historic period can be associated with factors like a surge in Bartonella disease cases, increased spending on healthcare, more resources being poured into research and development, an uptick in transmissible diseases, and a rise in the occurrence of infectious diseases.

What Growth Rate Is Forecasted for the Bartonellosis Market by 2029?

Anticipated to experience fast expansion in the upcoming years, the bartonellosis market is forecasted to escalate to a valuation of $2.03 billion by 2029, with a compound annual growth rate (CAGR) of 11.7%. Factors contributing to this anticipated growth during the prediction period include a surge in occurrences of zoonotic diseases, heightened comprehension of the disease, an increase in pet ownership, a rising focus on personalized medicine, and improved awareness about cat scratch disease. Noteworthy trends during this forecast period encompass breakthroughs in medical technology, progress in biotech, the emergence of combined testing, improved diagnostic techniques, and continued research and development.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21111&type=smp

Which Key Companies Are Shaping the Future of the Bartonellosis Market?

Major companies operating in the bartonellosis market are Mayo Clinic Laboratories, Northwell Health Labs, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., Alberta Precision Laboratories, Jiangsu BioPerfectus Technologies Co. Ltd., ARUP Laboratories, Surmodics Inc., Medical Diagnostic Laboratories LLC, Creative Biolabs, IGeneX Inc., Karius Inc., Synnovis Group LLP, Galaxy Diagnostics Inc., Gold Standard Diagnostics, Eurofins Biomnis, AMMAGENOMICS Private Limited, Ringbio

Which Factors Are Driving Demand in the Bartonellosis Industry?

An upsurge in the occurrence of diseases that transfer from animals to humans, known as zoonotic diseases, is projected to fuel the expansion of the bartonellosis market. This rise in zoonotic illnesses is attributed to several factors such as increased interaction between humans and animals, changes in the environment, deforestation, worldwide travel, and cross-species pathogen transmission. As a prime example of how bacterial pathogens transmitted via animal vectors like fleas, ticks, and lice can infect humans, bartonellosis supports zoonotic diseases. It presents a broad spectrum of clinical symptoms, underscoring the significance of comprehending vector-borne disease spread in the context of public health. For example, there were 159 samples of rabies submitted in November 2022, an increase from 135 submitted in October 2022, as per a January 2023 report by the Government of Canada, a Canada-based federal authority. Consequently, the increasing instances of zoonotic diseases are propelling the growth of the bartonellosis market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=21111&type=smp

How Is the Bartonellosis Market Segmented by Several Divisions?

The bartonellosis market covered in this report is segmented –

1) By Disease Type: Cat Scratch Disease (CSD), Trench Fever, Bartonella Endocarditis, Other Disease Types

2) By Diagnostic Method: Polymerase Chain Reaction (PCR) Testing, Serological Testing, Culture Methods, Histological Testing

3) By Treatment: Antibiotics, Antibacterial Agents, Supportive Care

4) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Cat Scratch Disease (CSD): Immunocompetent Hosts, Immunocompromised Hosts, Neurological Complications

2) By Trench Fever: Acute Trench Fever, Chronic Trench Fever, Asymptomatic Infections

3) By Bartonella Endocarditis: Native Valve Endocarditis, Prosthetic Valve Endocarditis, Bloodstream Infections

4) By Other Disease Types: Bacillary Angiomatosis, Parinaud’s Oculoglandular Syndrome, Bartonella-associated Vasculitis

What are the Emerging Market Trends Driving the Growth of the Bartonellosis Industry?

Leading firms in the bartonellosis market are concentrating their efforts on fundraising to advance early diagnosis and improve treatment options for the disease. These fundraising initiatives by organizations are vital in promoting research, diagnosis, treatment, and prevention of bartonellosis, which in turn drives innovation and enhances access to healthcare solutions. For example, in April 2022, the Global Lyme Alliance (GLA), a nonprofit organization based in the US, initiated a crowdfunding campaign with the aim of raising $300,000 for pioneering research on Bartonella, a covert pathogen that can trigger serious health problems including neuroinflammation and psychiatric conditions. The timing of this initiative was scheduled to coincide with Lyme disease awareness month, with the goal of enhancing knowledge about how Bartonella functions within the body, a key factor in developing more efficient treatments for Bartonella infections and associated diseases like Lyme. The campaign underlines the urgent need for increased awareness and funding to aid those suffering from these debilitating diseases.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/bartonellosis-global-market-report

Which Regions Are Driving Growth in the Bartonellosis Market?

North America was the largest region in the bartonellosis market in 2024. The regions covered in the bartonellosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21111

This Report Delivers Insight On:

1. How big is the bartonellosis market, and how is it changing globally?

2. Who are the major companies in the bartonellosis market, and how are they performing?

3. What are the key opportunities and risks in the bartonellosis market right now?

4. Which products or customer segments are growing the most in the bartonellosis market?

5. What factors are helping or slowing down the growth of the bartonellosis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model